Noxopharm
Noxopharm is an Australia-based biotechnology company that researches and develops oncotoxic and immuno-oncology molecule drugs to treat cancer and inflammatory diseases.
Business Model:
Revenue: $3.8M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Noxopharm Information
Geographic Data
Address: The Zenith 821 Pacific Highway
City: Chatswood
State: new south wales
Zip: 2067
Country: AU
Financial Info
Stage:
post ipo equity
Raised Last:
$17M
Raised Total:$18M
Social
Metrics
4,509,550Website Global Rank
2,367Website Monthly Traffic
Twitter Followers
Description
Noxopharm is an Australia-based biotechnology company that researches and develops oncotoxic and immuno-oncology molecule drugs to treat cancer and inflammatory diseases.
Contact Phone:
Contact Email:
Noxopharm went public on 8/12/2016 on the Australian Securities Exchange
Listed Exchange:
Australian Securities Exchange
IPO Date:
8/12/2016
Ticker Symbol:
NOX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2021 | Grant | $6.4M | 3/2018 | Private Placement | $10.8M | 6/2022 | Grant | $1M |
Victorian Government |
12/2022 | Grant | $34k |
CSIRO |
12/2020 | Post-IPO Equity | $17.1M | 7/2019 | Post-IPO Debt | 1 | $17.9M |
The Lind Partners The Lind Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
